🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Novel Surgical Criteria for Degenerative Cervical Myelopathy in Chinese Ethnicity

Recruitingn/aAges 45 Years - anyAllThe University of Hong Kong
NCT06528730 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Degenerative Cervical Myelopathy (DCM) is an age-related irreversible degenerative disease predominantly affecting the elderly aged 50 and over. DCM is usually triggered by ossification of the posterior longitudinal ligament or ossification of ligamentum flavum or prolapsed intervertebral disc over the cervical spine. Specific clinical signs characterized the presence of cervical spinal cord compression; including Hoffmann's sign, Finger Escape Sign, Scapulohumeral Reflex, and Reverse Supinator Reflex. Hand numbness, clumsiness, and gait disturbance. These are featured clinical manifestations and well-known indicators for detailed clinical and radiographic investigation, such as Magnetic Resonance Imaging (MRI) for diagnosis and surgical planning. Surgical intervention is considered to be the most effective treatment for DCM worldwide. It is the only evidence-based treatment to halt dis

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * MRI confirmed Chinese DCM surgical candidates * All gender * Older than 45 years old * Independent walkers * No previous cervical spinal surgery * Cognitively capable of following instructions. Exclusion Criteria: * Active diagnosis of tuberculosis spine * Lumbar spinal diseases * Extra-pyramidal * Cerebral or cerebellar disorders * Peripheral neuropathies * Previous spinal operations * Unable to walk independently with or without aids * Non-communicable subjects and cognitively incapable of expressing their symptoms clearly
💊

What it tests

  • DCM
📍

Where

1 site
The Duchess of Kent Children's Hospital at Sandy Bay
Hong Kong, Hong Kong
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy